NCT07805083 Community Enhanced Virtual Informed Consent
| NCT ID | NCT07805083 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2026-07-21 |
| Primary Completion | 2027-07-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2026-07-21 with a primary completion date of 2027-07-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages. This study will also examine how different informed consent approaches influence decisions to participate in research.
Eligibility Criteria
Inclusion Criteria: * Able to speak, read, or understand English sufficiently to provide informed consent * 18 years of age or older * White or Black * Living in the United States Exclusion Criteria: * Unable to speak, read, or understand English sufficiently to provide informed consent * Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Contact & Investigator
Janice L. Krieger, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07805083 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07805083 currently recruiting?
Yes, NCT07805083 is actively recruiting participants. Contact the research team at ETCH@mayo.edu for enrollment information.
Where is the NCT07805083 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT07805083 clinical trial?
NCT07805083 is sponsored by Mayo Clinic. The principal investigator is Janice L. Krieger, PhD at Mayo Clinic. The trial plans to enroll 600 participants.